Crohn´s Disease Clinical Trial
Official title:
Confocal Laser Endomicroscopy in Patients With Crohn´s Disease
Purpose:
The main objective of this study is to determine endomicroscopic features of Crohn´s
disease.
Background:
Crohn´s disease is an inflammatory disease of the intestines that may affect any part of the
gastrointestinal tract from anus to mouth, causing a wide variety of symptoms. Diagnosis is
based on several histologic features including transmural pattern of inflammation, crypt
abscesses and granulomas. Confocal laser endomicroscopy (CLE) is rapidly emerging as a
valuable tool for gastrointestinal endoscopic imaging, enabling the endoscopist to obtain an
"optical biopsy" of the gastrointestinal mucosa during the endoscopic procedure.
Scope:
In patients with Crohn´s disease.
Methods:
Patients underwent colonoscopy for the evaluation of Crohn´s disease. During the endoscopic
procedure CLE will be performed.
Procedure:
The patient underwent colonoscopy. During the procedure the patient will receive intravenous
fluorescein or topical mucosal staining with acriflavin or cresyl violet, followed by
in-vivo CLE of the tissue. Confocal images are digitally saved and analyzed afterwards.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01860651 -
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT01279577 -
Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease
|
Phase 2 | |
Completed |
NCT01086553 -
9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease
|
Phase 3 | |
Completed |
NCT02763293 -
Osteopathy Non-manipulative in Patients With Crohn's Disease.
|
N/A | |
Completed |
NCT01289366 -
Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)
|
N/A | |
Recruiting |
NCT06006039 -
The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.
|
||
Recruiting |
NCT04022083 -
Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
|
||
Completed |
NCT03890445 -
Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease
|
||
Completed |
NCT01564823 -
Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease
|
Phase 3 | |
Completed |
NCT01768858 -
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
|
||
Completed |
NCT01417702 -
Endoscopy for Assessment of Mucosal Healing in IBD
|
||
Completed |
NCT01417715 -
Endomicroscopy for Assessment of Mucosal Healing
|
||
Terminated |
NCT00862121 -
A Study With Pentasa in Patients With Active Crohn's Disease
|
Phase 3 |